UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000056228 |
|---|---|
| Receipt number | R000064153 |
| Scientific Title | Evaluating the Usefulness of Artificial Intelligence Simulated Patients in Medical Interviewing |
| Date of disclosure of the study information | 2024/11/21 |
| Last modified on | 2026/01/07 11:44:49 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Evaluating the Usefulness of Artificial Intelligence Simulated Patients in Medical Interviewing
Acronym
Evaluating the Usefulness of Artificial Intelligence Simulated Patients in Medical Interviewing
Scientific Title
Evaluating the Usefulness of Artificial Intelligence Simulated Patients in Medical Interviewing
Scientific Title:Acronym
Evaluating the Usefulness of Artificial Intelligence Simulated Patients in Medical Interviewing
Region
| Japan |
Condition
Condition
Not applicable
Classification by specialty
| Not applicable |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The objectives of this study are to give the AI the role of a simulated patient, conduct a simulated interview with a medical student, and evaluate its usefulness.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Medical interviews with simulated AI patients and medical interviews with simulated human patients will be evaluated using the mini-CEX (mini-Clinical Evaluation Exercise).
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -no one is blinded
Control
No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Educational,Counseling,Training
Type of intervention
| Other |
Interventions/Control_1
A medical student conducts a medical interview with a simulated human patient.
Interventions/Control_2
A medical student conducts a medical interview with a simulated AI patient.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 21 | years-old | <= |
Age-upper limit
| 50 | years-old | > |
Gender
Male and Female
Key inclusion criteria
The inclusion criteria for this study are medical students on a general medicine rotation at Chiba University School of Medicine from December 2024 to September 2025.
Key exclusion criteria
Exclusions include failure to obtain consent to participate in the study and failure to carry out the medical interview to the end of the study.
Target sample size
88
Research contact person
Name of lead principal investigator
| 1st name | Takanori |
| Middle name | |
| Last name | Uehara |
Organization
Chiba University Hospital
Division name
General Medicine
Zip code
260-8677
Address
1-8-1, Inohana, Chuo-ku, Chiba city
TEL
043-222-7171
takanori.ue@nifty.com
Public contact
Name of contact person
| 1st name | Yasutaka |
| Middle name | |
| Last name | Yanagita |
Organization
Chiba University Hospital
Division name
General Medicine
Zip code
260-8677
Address
1-8-1, Inohana, Chuo-ku, Chiba city
TEL
043-222-7171
Homepage URL
ahna5650@chiba-u.jp
Sponsor or person
Institute
Chiba University
Institute
Department
Personal name
Funding Source
Organization
Japan Medical Education Foundation
Organization
Division
Category of Funding Organization
Non profit foundation
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Chiba University
Address
1-8-1, Inohana, Chuo-ku, Chiba city
Tel
043-222-7171
igaku-rinri@office.chiba-u.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 11 | Month | 21 | Day |
Related information
URL releasing protocol
Publication of results
Partially published
Result
URL related to results and publications
NA
Number of participants that the trial has enrolled
48
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2024 | Year | 11 | Month | 11 | Day |
Date of IRB
| 2024 | Year | 11 | Month | 30 | Day |
Anticipated trial start date
| 2024 | Year | 12 | Month | 02 | Day |
Last follow-up date
| 2025 | Year | 09 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2024 | Year | 11 | Month | 21 | Day |
Last modified on
| 2026 | Year | 01 | Month | 07 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064153
